Miroslava Kissova

Dr. Miroslava Kissova

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
EMElisa Mentegari
Elisa Mentegari
Emmanuele CrespanEmmanuele Crespan
Emmanuele Crespan
LBLaura Bavagnoli
Laura Bavagnoli
MKMiroslava Kissova
Miroslava Kissova
FBFederica Bertoletti
Federica Bertoletti
Giovanni MagaGiovanni Maga
Giovanni Maga
Ribonucleotides (rNs) incorporated in the genome by DNA polymerases (Pols) are removed by RNase H2. Cytidine and guanosine preferentially accumulate over the other rNs. Here we show that human Pol eta can incorporate cytidine monophosphate (rCMP) opposite guanine, 8-oxo-7,8-dihydroguanine, 8-methyl-2'- deoxyguanosine and a cisplatin intrastrand guanine crosslink (cis-PtGG), while it cannot bypass a 3-methylcytidine or an abasic site with rNs as substrates. Pol eta is also capable of synthesizing polyribonucleotide chains, and its activity is enhanced by its auxiliary factor DNA Pol delta interacting protein 2 (PolDIP2). Human RNase H2 removes cytidine and guanosine less efficiently than the other rNs and incorporation of rCMP opposite DNA lesions further reduces the efficiency of RNase H2. Experiments with XP-V cell extracts indicate Pol eta as the major basis of rCMP incorporation opposite cis-PtGG. These results suggest that translesion synthesis by Pol eta can contribute to the accumulation of rCMP in the genome, particularly opposite modified guanines.

10 February 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
STSabrina Tassini
Sabrina Tassini
LSLiang Sun
Liang Sun
KLKristina Lanko
Kristina Lanko
Emmanuele CrespanEmmanuele Crespan
Emmanuele Crespan
ELEmily Langron
Emily Langron
MRMarco Radi
Marco Radi

1 February 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Francesca MusumeciFrancesca Musumeci
Francesca Musumeci
AFAnna Lucia Fallacara
Anna Lucia Fallacara
CBChiara Brullo
Chiara Brullo
GGGiancarlo Grossi
Giancarlo Grossi
LBLorenzo Botta
Lorenzo Botta
Silvia SchenoneSilvia Schenone
Silvia Schenone

1 November 2018 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AMAlessio Molinari
Alessio Molinari
AFAnna Lucia Fallacara
Anna Lucia Fallacara
SMSalvatore Di Maria
Salvatore Di Maria
CZClaudio Zamperini
Claudio Zamperini
FPFederica Poggialini
Federica Poggialini
MBMaurizio Botta
Maurizio Botta

28 June 2013 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
CTCristina Tintori
Cristina Tintori
Ilaria LaurenzanaIlaria Laurenzana
Ilaria Laurenzana
FRFrancesco La Rocca
Francesco La Rocca
FFFederico Falchi
Federico Falchi
FCFabio Carraro
Fabio Carraro
MBMaurizio Botta
Maurizio Botta

31 August 2016 in Genes
Verified
Journal Article
Open access
PDF file
EMElisa Mentegari
Elisa Mentegari
MKMiroslava Kissova
Miroslava Kissova
LBLaura Bavagnoli
Laura Bavagnoli
Giovanni MagaGiovanni Maga
Giovanni Maga
Emmanuele CrespanEmmanuele Crespan
Emmanuele Crespan
DNA is constantly exposed to both endogenous and exogenous damages. More than 10,000 DNA modifications are induced every day in each cell’s genome. Maintenance of the integrity of the genome is accomplished by several DNA repair systems. The core enzymes for these pathways are the DNA polymerases. Out of 17 DNA polymerases present in a mammalian cell, at least 13 are specifically devoted to DNA repair and are often acting in different pathways. DNA polymerases β and λ are involved in base excision repair of modified DNA bases and translesion synthesis past DNA lesions. Polymerase λ also participates in non-homologous end joining of DNA double-strand breaks. However, recent data have revealed that, depending on their relative levels, the cell cycle phase, the ratio between deoxy- and ribo-nucleotide pools and the interaction with particular auxiliary proteins, the repair reactions carried out by these enzymes can be an important source of genetic instability, owing to repair mistakes. This review summarizes the most recent results on the ambivalent properties of these enzymes in limiting or promoting genetic instability in mammalian cells, as well as their potential use as targets for anticancer chemotherapy.